Back to Search Start Over

Data indicate potential for Ad-IL2 cancer immunotherapy program.

Source :
Biotech Week; 5/12/2004, p515-517, 3p
Publication Year :
2004

Abstract

Details results from Transgene's phase I/II clinical trial in patients with melanoma and other solid tumors as well as results from pre-clinical experiments in animal tumor models.

Details

Language :
English
ISSN :
15352757
Database :
Supplemental Index
Journal :
Biotech Week
Publication Type :
Periodical
Accession number :
13031832